Rybelsus is available as tablets to be taken by mouth once a day and can only be obtained with a prescription. Patients should start on the lowest dose, which is increased to a maintenance dose after one month. After at least one month on this dose, the dose can be increased to the next higher dose if needed.| European Medicines Agency (EMA)
EMA and the Heads of Medicines Agencies (HMAs) have published an artificial intelligence (AI) workplan to 2028, setting out a collaborative and coordinated strategy to maximise the benefits of AI to stakeholders while managing the risks.| European Medicines Agency (EMA)
Measure taken as precaution while review of emerging data is ongoing| European Medicines Agency (EMA)
EMA's Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) met on Thursday to discuss the progress made and to agree on the next steps in the coordinated response to the ongoing shortages of antibiotic medicines containing amoxicillin (alone and in combination with clavulanic acid) in the EU. The MSSG is made up of representatives from EMA, the European Commission and the Heads of Medicines Agencies (HMA).| European Medicines Agency (EMA)
The European Medicines Agency is a decentralised agency of the European Union responsible for the evaluation, supervision and safety monitoring of medicines.| European Medicines Agency (EMA)
EMA’s safety committee, the PRAC, is reviewing data on the risk of suicidal thoughts and thoughts of self-harm with medicines known as GLP-1 receptor agonists,1 including Ozempic (semaglutide), Saxenda (liraglutide) and Wegovy (semaglutide). These medicines are used for weight loss and for treating type 2 diabetes.| European Medicines Agency (EMA)
